AU2002330801A1 - Method for oral transmucosal delivery of interferon - Google Patents
Method for oral transmucosal delivery of interferonInfo
- Publication number
- AU2002330801A1 AU2002330801A1 AU2002330801A AU2002330801A AU2002330801A1 AU 2002330801 A1 AU2002330801 A1 AU 2002330801A1 AU 2002330801 A AU2002330801 A AU 2002330801A AU 2002330801 A AU2002330801 A AU 2002330801A AU 2002330801 A1 AU2002330801 A1 AU 2002330801A1
- Authority
- AU
- Australia
- Prior art keywords
- interferon
- transmucosal delivery
- oral transmucosal
- oral
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU2002/000300 WO2004000266A1 (en) | 2002-06-20 | 2002-06-20 | Method for oral transmucosal delivery of interferon |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002330801A1 true AU2002330801A1 (en) | 2004-01-06 |
Family
ID=29997637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002330801A Abandoned AU2002330801A1 (en) | 2002-06-20 | 2002-06-20 | Method for oral transmucosal delivery of interferon |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002330801A1 (en) |
WO (1) | WO2004000266A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040258663A1 (en) * | 2003-05-08 | 2004-12-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of interferon alpha |
WO2016169571A1 (en) * | 2015-04-20 | 2016-10-27 | Ghaleb Haider Abbas | Pharmaceutical product for treatment & prophylaxis of viral/ microbial infection |
EP3801599A1 (en) * | 2018-06-01 | 2021-04-14 | ILC Therapeutics Ltd | Compositions and methods relating to the treatment of diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5017371A (en) * | 1988-01-06 | 1991-05-21 | Amarillo Cell Culture Company, Incorporated | Method for reducing side effects of cancer therapy |
MX9102512A (en) * | 1990-12-14 | 1992-06-01 | Schering Corp | ORAL ADMINISTRATION OF ALPHA INTERFERON IN THE TREATMENT OF LUNG DISEASES. |
WO1997025862A1 (en) * | 1996-01-19 | 1997-07-24 | Mcgill University | Hepatitis pretreatment composition and method |
US20010043906A1 (en) * | 1999-12-30 | 2001-11-22 | Vlasselaer Peter Van | gamma-IFN liquid-droplet aerosol and method |
-
2002
- 2002-06-20 AU AU2002330801A patent/AU2002330801A1/en not_active Abandoned
- 2002-06-20 WO PCT/RU2002/000300 patent/WO2004000266A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004000266A1 (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002319653A1 (en) | Method for oral drug delivery | |
AU2003284115A1 (en) | Method of delivering local anesthesia | |
AU2003209475A1 (en) | Fast melt multiparticulate formulations for oral delivery | |
AU2003280373A1 (en) | Method of administering bisphosphonates | |
IL165172A0 (en) | Compositions and method for enhanced mucosal delivery of interfern beta | |
AU2003299849A1 (en) | Drug delivery apparatus | |
AU2003211376A1 (en) | Drug administration method | |
EP1478345A4 (en) | Novel pharmaceutical dosage forms and method for producing same | |
EP1383518A4 (en) | Oral delivery of macromolecules | |
AU2003284387A1 (en) | Delivery composition and method | |
IL166337A0 (en) | Oral administration of calctionin | |
AU2003277596A1 (en) | Method of deuterization | |
AU2003290436A1 (en) | Oral preparation system | |
AU2003276688A1 (en) | Pharmaceutical composition of metaxalone with enhanced oral bioavailability | |
AU2002330801A1 (en) | Method for oral transmucosal delivery of interferon | |
AU2002308649A1 (en) | Compositions and methods for enhancing drug delivery | |
WO2003067458A8 (en) | Parts ordering system for improving efficiency of parts delivery | |
AU2003284786A1 (en) | Microemulsion composition for oral administration of biphenyldimethyldicarboxylate | |
AU2003302185A1 (en) | Orthodontic wire and method for making same | |
AU2003289462A1 (en) | Method for producing ceramic structure | |
AU2003263384A1 (en) | Orthodontic apparatus | |
AU2003236892A1 (en) | Dental elevator | |
AU2003244092A1 (en) | 1ss-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION | |
PL372298A1 (en) | Method for producing interferon | |
AU2003266612A1 (en) | Method of measuring glycoprotein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |